000 01431 a2200409 4500
005 20250513084602.0
264 0 _c19960305
008 199603s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0922-4106(95)90144-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHerzer, T
245 0 0 _aEffect of channel modulation and pH on IsK inhibition by the novel class III antiarrhythmic azimilide (NE-10064).
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cOct 1995
300 _a205-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Arrhythmia Agents
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEvoked Potentials
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydantoins
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aImidazolidines
650 0 4 _aIsoproterenol
_xpharmacology
650 0 4 _aOocytes
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aPotassium Channels
_xdrug effects
650 0 4 _aXenopus
700 1 _aWagner, C A
700 1 _aWaldegger, S
700 1 _aLang, F
700 1 _aBusch, A E
773 0 _tEuropean journal of pharmacology
_gvol. 291
_gno. 2
_gp. 205-8
856 4 0 _uhttps://doi.org/10.1016/0922-4106(95)90144-2
_zAvailable from publisher's website
999 _c8565244
_d8565244